The TSX-listed Canadian stocks on our list have seen their stock prices rally at least 15% over the past week on higher-than-normal volume
SmallCapPower | September 20, 2021: Today we have found four small Canadian stocks that have experienced increased price and volume momentum, with a seven-day, stock-price return greater than 10% and with seven-day average trading volume greater than 30-day average trading volume. Positive price momentum combined with a large trading volume increase is a powerful combination, especially for smaller-cap stocks and micro-cap names, as increased share prices on strong volumes show increased investor interest in a stock.
*Share price data and other metrics as of September 17, 2021
exactEarth Ltd. (TSX:XCT) – $3.34
Data Services – Transportation
exactEarth is a publicly-traded data services company delivering real-time global location-based maritime vessel tracking information utilizing patented satellite AIS detection technology. exactEarth provides satellite AIS data services to commercial markets as well as government customers in India, Canada, United States, Australia and across Europe. XCT is currently the market leader in Satellite-Based Vessel Tracking and provider of data and analytics for global maritime awareness. Their second-generation global real-time AIS system now fully operational with real-time service expands addressable market opportunity. exactEarth has a subscription-based revenue model with high potential for margin expansion and growing adjusted EBITDA.
- Market Cap: $166.4M
- 7-Day Share Price Return: +130.3%
- 30-Day Return: +147.4%
- 7-Day Average Trading Volume: 170,710
- 30-Day Average Trading Volume: 52,890
BELLUS Health Inc. (TSX:BLU) – $7.72
BELLUS Health is a clinical stage pharmaceutical company focused on developing a P2X3 antagonist to address various afferent hypersensitization-related disorders, which have a large patient population, estimated at 9m in U.S., with significant unmet need. The Company’s lead candidate, BLU-5937, is currently being studied in Phase 2 clinical trials in refractory chronic cough and chronic pruritus associated with atopic dermatitis. First generation P2X3 antagonist in Phase 3, Merck’s MK-7264: reduces cough but leads to taste alteration/loss in 58-69% of patients. Positive interim analysis (September) with at least 1 dose meeting the threshold for a high probability of clinical efficacy; SOOTHE Phase 2b trial topline expected in 4Q 2021.
- Market Cap: $604.8M
- 7-Day Share Price Return: +54.7%
- 30-Day Return: +93.0%
- 7-Day Average Trading Volume: 480,660
- 30-Day Average Trading Volume: 175,330
Electrovaya Inc. (TSX:EFL) – $1.21
Electrovaya is a pure play developer and manufacturer of portable Lithium-ion batteries and battery management systems for the automotive, warehousing, autonomous guided vehicles, power grid, medical, and mobile device sectors. The Company is based in Toronto, Canada.
- Market Cap: $173.1M
- 7-Day Share Price Return: +26.0%
- 30-Day Return: +31.5%
- 7-Day Average Trading Volume: 154,880
- 30-Day Average Trading Volume: 102,040
TerraVest Industries Inc. (TSX:TVK) – $25.56
TerraVest Industries is a market leading manufacturer of home heating products, propane, anhydrous ammonia (NH3) and natural gas liquids (NGL) transport vehicles and storage vessels, energy processing equipment and fiberglass storage tanks. The Company’s expertise is in manufacturing steel and fiberglass products.
- Market Cap: $449.0M
- 7-Day Share Price Return: +14.7%
- 30-Day Return: +28.1%
- 7-Day Average Trading Volume: 9,980
- 30-Day Average Trading Volume: 5,950
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below: